A fascinating traversal of all six concertos in all their colourful variety given compelling performances by the Orchestra of ...

Rapt Therapeutics Inc ( (RAPT) ) has released its Q3 earnings. Here is a breakdown of the information Rapt Therapeutics Inc presented to its ...

The debut album from Lindsey Buckingham and Stevie Nicks just before they joined Fleetwood Mac has been out of print for ...

The trial, expected to span several months, continues to hold Chicago’s rapt attention as each day brings forth more insight ...

In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on RAPT Therapeutics (RAPT – Research Report), with a price target of $4.00. Yanan Zhu’s rating is based on RAPT ...

Outer Banks Season 4 was a thrilling emotional rollercoaster. But we discuss why the penultimate season wasn't without flaws.

Fintel reports that on November 11, 2024, JP Morgan downgraded their outlook for RAPT Therapeutics (NasdaqGM:RAPT) from ...

U.S. stocks were higher after the close on Monday, as gains in the Consumer Goods, Financials and Industrials sectors led ...

Rapt Therapeutics is officially shelving its mid-stage immunology candidate after a case of liver failure triggered clinical ...

Shares of RAPT Therapeutics touched an all-time low following news the company terminated its zelnecirnon program after feedback from the Food and Drug Administration. In the last hour of Monday's ...

Shares of RAPT Therapeutics (RAPT) plunged 46% Monday after the company said it was scrapping development of its drug ...

In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.